181 related articles for article (PubMed ID: 1563446)
1. Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
Kuwert T; Hefter H; Scholz D; Milz M; Weiss P; Arendt G; Herzog H; Loken M; Hennerici M; Feinendegen LE
Eur J Nucl Med; 1992; 19(2):96-101. PubMed ID: 1563446
[TBL] [Abstract][Full Text] [Related]
2. Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI.
Schlaug G; Hefter H; Engelbrecht V; Kuwert T; Arnold S; Stöcklin G; Seitz RJ
J Neurol Sci; 1996 Mar; 136(1-2):129-39. PubMed ID: 8815159
[TBL] [Abstract][Full Text] [Related]
3. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.
Schlaug G; Hefter H; Nebeling B; Engelbrecht V; Weiss P; Stöcklin G; Seitz RJ
J Neurol; 1994 Oct; 241(10):577-84. PubMed ID: 7836960
[TBL] [Abstract][Full Text] [Related]
5. Wilson's disease studied with FDG and positron emission tomography.
Hawkins RA; Mazziotta JC; Phelps ME
Neurology; 1987 Nov; 37(11):1707-11. PubMed ID: 3499583
[TBL] [Abstract][Full Text] [Related]
6. Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.
De Volder A; Sindic CJ; Goffinet AM
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):947-9. PubMed ID: 3264567
[TBL] [Abstract][Full Text] [Related]
7. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.
Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
Brain; 1990 Oct; 113 ( Pt 5)():1405-23. PubMed ID: 2147116
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebral metabolic rate for glucose in subacute sclerosing panencephalitis.
Yanai K; Iinuma K; Tada K; Miyabayashi S; Fukuda H; Ito M; Matsuzawa T
Eur J Pediatr; 1987 May; 146(3):288-9. PubMed ID: 3496222
[TBL] [Abstract][Full Text] [Related]
9. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE
Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813
[TBL] [Abstract][Full Text] [Related]
10. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease.
Kuwert T; Lange HW; Boecker H; Titz H; Herzog H; Aulich A; Wang BC; Nayak U; Feinendegen LE
J Neurol; 1993 Nov; 241(1):31-6. PubMed ID: 8138819
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.
Cordato DJ; Fulham MJ; Yiannikas C
Mov Disord; 1998 Jan; 13(1):162-6. PubMed ID: 9452344
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions.
Hermann W; Barthel H; Hesse S; Grahmann F; Kühn HJ; Wagner A; Villmann T
J Neurol; 2002 Jul; 249(7):896-901. PubMed ID: 12140675
[TBL] [Abstract][Full Text] [Related]
13. Influence of size of regions of interest on PET evaluation of caudate glucose consumption.
Kuwert T; Ganslandt T; Jansen P; Jülicher F; Lange H; Herzog H; Scholz D; Aulich A; Feinendegen LE
J Comput Assist Tomogr; 1992; 16(5):789-94. PubMed ID: 1387888
[TBL] [Abstract][Full Text] [Related]
14. PET studies of cerebral glucose metabolism in conscious rhesus macaques.
Eberling JL; Roberts JA; De Manincor DJ; Brennan KM; Hanrahan SM; Vanbrocklin HF; Roos MS; Jagust WJ
Neurobiol Aging; 1995; 16(5):825-32. PubMed ID: 8532117
[TBL] [Abstract][Full Text] [Related]
15. Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography.
Kuwert T; Lange HW; Langen KJ; Herzog H; Hefter H; Aulich A; Feinendegen LE
J Neurol; 1990 Apr; 237(2):80-4. PubMed ID: 2141358
[TBL] [Abstract][Full Text] [Related]
16. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600.
Nordahl TE; Kusubov N; Carter C; Salamat S; Cummings AM; O'Shora-Celaya L; Eberling J; Robertson L; Huesman RH; Jagust W; Budinger TF
Neuropsychopharmacology; 1996 Dec; 15(6):541-54. PubMed ID: 8946428
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of two population-based input functions for quantitative neurological FDG PET studies.
Eberl S; Anayat AR; Fulton RR; Hooper PK; Fulham MJ
Eur J Nucl Med; 1997 Mar; 24(3):299-304. PubMed ID: 9143468
[TBL] [Abstract][Full Text] [Related]
18. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Momose T; Matsui T; Kosaka N; Ohtake T; Watanabe T; Nishikawa J; Abe K; Tanaka J; Takakura K; Iio M
Radiat Med; 1989; 7(5):243-6. PubMed ID: 2629037
[TBL] [Abstract][Full Text] [Related]
19. The metabolic anatomy of paraneoplastic cerebellar degeneration.
Anderson NE; Posner JB; Sidtis JJ; Moeller JR; Strother SC; Dhawan V; Rottenberg DA
Ann Neurol; 1988 Jun; 23(6):533-40. PubMed ID: 3261571
[TBL] [Abstract][Full Text] [Related]
20. Posthypoxic amnesia: regional cerebral glucose consumption measured by positron emission tomography.
Kuwert T; Hömberg V; Steinmetz H; Unverhau S; Langen KJ; Herzog H; Feinendegen LE
J Neurol Sci; 1993 Aug; 118(1):10-6. PubMed ID: 8229044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
